Director’s report and financial statements for the year ended 30th June 2019. To download this report as a PDF file click here.
Final Report and Accounts2019-11-152019-11-15https://www.bioventix.com/wp-content/uploads/bioventix-logo-colour.pngBioventix – The Sheep Monoclonal Antibody Companyhttps://www.bioventix.com/wp-content/uploads/bioventix-logo-colour.png200px200px
Bioventix plc is an AIM listed company. This site contains key corporate, financial and shareholder information. The information disclosed is for the purposes of AIM Rule 26. Bioventix plc is subject to the UK City Code on Takeovers and Mergers.